HealthDay News — In a case report published online March 25 in the International Journal of Eating Disorders, elevated serum carcinoembryonic antigen (CEA) levels are observed in a male patient with ...

The objective of this investigation was to assess whether preoperative carcinoembryonic antigen (CEA) level is an independent predictor of overall survival in rectal cancer patients. Before rectal ...

Tissue microarray analysis to evaluate the role of heat shock protein 27 as a potential biomarker in pancreatic cancer. Background: The usefulness of tumor markers in NSCLC is not well defined. High ...

Three major oncology organizations recommend that CEA be measured in patients with nonmetastatic colorectal cancer prior to surgical resection. In the current analysis, patients with a normal ...

The main limitation of current cancer therapy is the development of metastatic disease which, in most patients, is not curable. In colon cancer, which counts for approximately one-third of all cancer ...

A 57-year-old male was diagnosed with adenocarcinoma of the lung approximately 1 year ago following a routine screening CT scan of chest. The disease was initially thought to be a stage I solitary ...

Epidemiology of rectal and small intestinal carcinoids: Two distinct tumors? Background: Serum carcinoembryonic antigen (CEA) level can be used as a sensitive marker of recurrence in the follow up of ...

(HealthDay)—Colon cancer patients with elevated preoperative carcinoembryonic antigen (CEA) levels that normalize after resection are not at increased risk for poor prognosis, according to a study ...

A blood test that detects carcinoembryonic antigen (CEA) can improve preoperative risk stratification for patients with stage II colon cancer and guide decisions about adjuvant chemotherapy, say ...

Using RECIST criteria for tumor progression and disease response, the mean change in CEA for patients with progression was an increase in 19 ng/mL, compared to a change of –7.3 ng/mL in those with ...